Security key
92764N102
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR)
CUSIP: 92764N102
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 168,432,200
- Total 13F shares
- 88,814,549
- Share change
- +696,867
- Total reported value
- $899,654,431
- Put/Call ratio
- 103%
- Price per share
- $10.13
- Number of holders
- 205
- Value change
- +$7,160,790
- Number of buys
- 100
- Number of sells
- 92
Report period
Q1 2024
Institutions
205
Top holders
10
VIR full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92764N102
Recent filing periods:
Top shareholders of VIR - Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
10%
|
16,864,579
|
$169,657,665 | — | 31 Dec 2023 | |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
|
Company |
9.9%
|
16,684,041
|
$167,841,452 | — | 31 Dec 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
7.3%
|
12,297,139
|
$123,709,219 | — | 31 Dec 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.1%
|
6,912,082
|
$69,535,545 | — | 31 Dec 2023 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
2.4%
|
3,965,549
|
$39,893,423 | — | 31 Dec 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
1.8%
|
3,037,948
|
$30,561,757 | — | 31 Dec 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
1.7%
|
2,781,049
|
$27,977,353 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
1.3%
|
2,126,279
|
$21,390,372 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,886,396
|
$18,979,187 | — | 31 Dec 2023 | |
| Gates Foundation |
13F
|
Company |
0.93%
|
1,559,142
|
$15,684,969 | — | 31 Dec 2023 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.8%
|
1,343,904
|
$13,519,674 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.77%
|
1,294,600
|
$13,024,000 | — | 31 Dec 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.56%
|
937,304
|
$9,429,278 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.46%
|
769,144
|
$7,737,589 | — | 31 Dec 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.45%
|
753,073
|
$7,575,915 | — | 31 Dec 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.43%
|
720,898
|
$7,252,235 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.34%
|
577,757
|
$5,812,235 | — | 31 Dec 2023 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
553,806
|
$5,571,288 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.31%
|
526,180
|
$5,293,371 | — | 31 Dec 2023 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.3%
|
507,627
|
$5,106,727 | — | 31 Dec 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.28%
|
468,319
|
$4,712,709 | — | 31 Dec 2023 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.28%
|
465,489
|
$4,682,819 | — | 31 Dec 2023 | |
| BARCLAYS PLC |
13F
|
Company |
0.26%
|
444,694
|
$4,473,622 | — | 31 Dec 2023 | |
| Empowered Funds, LLC |
13F
|
Company |
0.25%
|
423,404
|
$4,259,444 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.24%
|
410,057
|
$4,125,173 | — | 31 Dec 2023 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.24%
|
398,970
|
$4,013,638 | — | 31 Dec 2023 | |
| TWINBEECH CAPITAL LP |
13F
|
Company |
0.19%
|
319,872
|
$3,217,912 | — | 31 Dec 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.19%
|
312,752
|
$3,146,286 | — | 31 Dec 2023 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
0.17%
|
293,476
|
$2,952,369 | — | 31 Dec 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.17%
|
290,017
|
$2,917,571 | — | 31 Dec 2023 | |
| Hudson Bay Capital Management LP |
13F
|
Company |
0.17%
|
290,000
|
$2,917,400 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.16%
|
275,458
|
$2,771,084 | — | 31 Dec 2023 | |
| Corient Private Wealth LLC |
13F
|
Company |
0.16%
|
267,279
|
$2,688,827 | — | 31 Dec 2023 | |
| Capital International Investors |
13F
|
Company |
0.15%
|
258,400
|
$2,599,504 | — | 31 Dec 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.15%
|
244,567
|
$2,460,344 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
226,547
|
$2,279,063 | — | 31 Dec 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.13%
|
221,855
|
$2,231,861 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.13%
|
218,389
|
$2,196,993 | — | 31 Dec 2023 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.13%
|
213,189
|
$2,144,679 | — | 31 Dec 2023 | |
| Mirae Asset Global Investments Co., Ltd. |
13F
|
Company |
0.13%
|
212,902
|
$2,141,794 | — | 31 Dec 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.12%
|
208,300
|
$2,095,498 | — | 31 Dec 2023 | |
| CITIGROUP INC |
13F
|
Company |
0.12%
|
206,021
|
$2,072,572 | — | 31 Dec 2023 | |
| Swiss National Bank |
13F
|
Company |
0.11%
|
185,200
|
$1,863,112 | — | 31 Dec 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.11%
|
183,824
|
$1,849,269 | — | 31 Dec 2023 | |
| PUBLIC SECTOR PENSION INVESTMENT BOARD |
13F
|
Company |
0.11%
|
178,659
|
$1,797,310 | — | 31 Dec 2023 | |
| State of Alaska, Department of Revenue |
13F
|
Company |
0.09%
|
152,965
|
$1,538,000 | — | 31 Dec 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.09%
|
152,345
|
$1,532,590 | — | 31 Dec 2023 | |
| Gamma As Sector |
13F
|
Individual |
0.09%
|
148,538
|
$1,494,292 | — | 31 Dec 2023 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.09%
|
148,474
|
$1,502,557 | — | 31 Dec 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.08%
|
138,226
|
$1,391,000 | — | 31 Dec 2023 |
Institutional Holders of Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) as of Q1 2024
As of 31 Mar 2024,
Vir Biotechnology, Inc. - Common Stock, $0.0001 par value (VIR) was held by
205 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,814,549 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, BAILLIE GIFFORD & CO, CITADEL ADVISORS LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Bill & Melinda Gates Foundation, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
206
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
202
Q1 2024 holders
205
Holder diff
3
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.